Conditions: Obesity Schizophrenia Schizoaffective Disorder
Keywords: obesity schizophrenia schizoaffective disorder weight loss
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 24
Healthy volunteers: no

Brief summary:
The purpose of this clinical trial is to find out how effective low dose oral naltrexone is on reducing body weight when compared to placebo in women with schizophrenia and schizoaffective disorder.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Naltrexone 25mg intervention 2: Placebo
Intervention descriptions: intervention 1: Naltrexone 25mg caplets taken orally once a day for 8 weeks intervention 2: Placebo caplet (inactive substance) taken orally once a day for 8 weeks

Protocol document: